info@seagull-health.com
SeagullHealth
语言:
search
new
How to purchase caplacizumab?
501
Article source: Seagull Pharmacy
Jul 09, 2025

Caplacizumab, also known as Cablivi, is a drug specifically used to treat acquired thrombotic thrombocytopenic purpura (aTTP) in adults. This article will discuss how to purchase the drug, precautions for special populations, and foods that patients should avoid, to help readers fully understand and correctly use this innovative therapy.

How to purchase caplacizumab?

Obtaining caplacizumab is important for patients with aTTP. Since it is not yet available in China, it needs to be purchased through specific channels.

International procurement channels

Considering that caplacizumab is not sold in the Chinese market, patients can purchase it from the original drug manufacturer Sanofi through an international procurement platform.

Assistance from medical institutions

Contacting overseas medical institutions is also a feasible method. This not only helps patients obtain the drugs they need, but also provides professional medical guidance and support. By working with a professional team, patients can better understand the treatment plan and get the best care services.

Whether through international procurement or assistance from medical institutions, choosing the right purchase method has a direct impact on the patient's treatment process.

Use of Caplacizumab in Special Populations

When using Caplacizumab in special populations, special attention must be paid to potential risks and indications. The following is a detailed introduction.

Pregnant and lactating women

Pregnant women are at risk of bleeding in both the mother and the fetus when using Caplacizumab. Lactating women need to weigh the impact of breastfeeding on the child's development and their own clinical needs. For this group, before deciding whether to use Caplacizumab, they should consult a doctor in detail.

Elderly people and people with impaired liver function

There is limited research data on Caplacizumab in the elderly population, and patients with severe liver damage should use it with caution due to the increased risk of bleeding. It is particularly important to develop personalized treatment plans for people with different health conditions.

Fully considering the specific conditions of special populations will help develop more reasonable and safe treatment strategies.

Contraindications for patients with Caplacizumab

Although it is not explicitly stated that Caplacizumab has specific food contraindications, patients still need to pay attention to their eating habits during treatment to promote overall health.

Avoid high-risk foods

Avoid eating foods that may increase bleeding tendency, such as garlic, ginkgo and other natural products with anticoagulant effects, to prevent increased bleeding risk. Choosing mild and nutritious foods can help maintain good health without affecting the efficacy of drugs.

Increase the intake of foods rich in vitamin K

Increasing the intake of foods rich in vitamin K, such as green leafy vegetables, can help balance the coagulation mechanism in the body, but be careful not to overdo it. A reasonable dietary structure is not only conducive to physical recovery, but also helps drugs to achieve the best effect.

Reasonable adjustment of eating habits and drug treatment can effectively improve the treatment effect and promote the recovery process.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Caplacizumab(Cablivi)
Caplacizumab(Cablivi)
CABLIVI (caplacizumab-yhdp) is specifically indicated for the treatment of...
WeChat Scan
Free Inquiry
Recommended Articles
Instructions for Caplacizumab
Caplacizumab is a nano-antibody drug, mainly used to treat acquired thrombotic thrombocytopenic purpura (aTTP) in adults. It blocks the interaction between von Willebrand factor (vWF) and platelets, r...
Indications of Caplacizumab
Caplacizumab was approved by the U.S. Food and Drug Administration (FDA) in 2019 for marketing under the trade name CABLIVI for the treatment of acquired thrombotic thrombocytopenic purpura (aTTP...
Precautions for Ambrisentan (Endobloc)
As an important medical drug for the treatment of pulmonary hypertension, Ambrisentan requires patients and medical staff to strictly abide by certain precautions during its use. This article wil...
What are the serious side effects of Ambrisentan?
Ambrisentan is a drug used to treat pulmonary arterial hypertension (PAH). It improves patients' motor ability and delays disease progression by selectively inhibiting ETA receptors. Despite ...
How much does Caplacizumab cost per bottle?
Caplacizumab is an innovative drug used to treat acquired thrombotic thrombocytopenic purpura (aTTP) in adults. It improves the patient's condition by blocking the interaction between von Wil...
How to use Caplacizumab
Caplacizumab is a nano-antibody drug used to treat acquired thrombotic thrombocytopenic purpura (aTTP) in adults. It works by blocking the interaction between von Willebrand factor (vWF) and plat...
The role of caplacizumab
Caplacizumab, also known as Cablivi, is a drug specifically used to treat acquired thrombotic thrombocytopenic purpura (aTTP) in adults. This article will explore its mechanism of action, efficacy, an...
Instructions for Caplacizumab: Precautions, Actions and Efficacy, Usage and Dosage, Side Effects
Caplacizumab is a nano-antibody drug used to treat acquired thrombotic thrombocytopenic purpura (aTTP) in adults. It reduces platelet consumption by blocking the interaction between von Willebran...
Related Articles
Precautions for Using Caplacizumab
Caplacizumab is a specific drug for the treatment of acquired thrombotic thrombocytopenic purpura (aTTP) in adults, manufactured by the French company Sanofi. Since this drug has not yet been launched...
Side Effects of Caplacizumab
Caplacizumab is a specific drug for the treatment of acquired thrombotic thrombocytopenic purpura (aTTP) in adults.  Since this drug has not yet been launched in China and is not included in the ...
Therapeutic Effects of Caplacizumab
Caplacizumab is an innovative therapeutic drug for acquired thrombotic thrombocytopenic purpura (aTTP) in adults. Its unique nanobody technology platform and significant therapeutic effects have broug...
Latest Price of Caplacizumab in 2025
Caplacizumab is a nanobody drug used for the treatment of acquired thrombotic thrombocytopenic purpura (aTTP) in adults, manufactured by Sanofi (France). It has not yet been launched in China and is n...
Dosage and Administration of Caplacizumab (Cablivi)
Caplacizumab must be used in conjunction with plasma exchange and immunosuppressive therapy. Precise timing of medication administration and standardized injection techniques are crucial for ensuring ...
Caplacizumab (Cablivi):Clinical Uses, Recommended Dosage, Treatment Effect
Caplacizumab (Cablivi) is a targeted therapeutic agent classified as a monoclonal antibody fragment (nanobody), primarily indicated for the treatment of adult acquired thrombotic thrombocytopenic purp...
Effects and efficacy of Caplacizumab
Caplacizumab is a drug specifically used to treat acquired thrombotic thrombocytopenic purpura (aTTP) in adults. This article will explore its effects and efficacy, possible adverse reactions, an...
Instructions for Caplacizumab: Precautions, Actions and Efficacy, Usage and Dosage, Side Effects
Caplacizumab is a nano-antibody drug used to treat acquired thrombotic thrombocytopenic purpura (aTTP) in adults. It reduces platelet consumption by blocking the interaction between von Willebran...
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved